Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent
Heng GeQing ZhangWei ZhouQing HeZhihua HanBen He
Abstract
DES-ISR patients had a poorer prognosis than BMS-ISR patients after DES therapy.
Metrics
Citation History
Topics
Related Documents
Bare metal stent implantation for in-stent restenosis with a drug-eluting stent
Hiroshi MatsuokaHideo KawakamiAkira OhshitaTamami KohnoSusumu ShigemiHideki OkayamaJitsuo Higaki
TCT-628 Drug-eluting stent implantation for the treatment of bare-metal or drug-eluting stent restenosis
Shintaro NezuoHiroyuki OkuraKenzo FukuharaTeruyoshi KumeAkihiro HayashidaYoji NeishiTakahiro KawamotoKiyoshi Yoshida
Repeated Sirolimus-Eluting Stent Implantation to Treat Sirolimus-Eluting Stent and Bare-Metal Stent Restenosis
Kensaku NishihiraYoshisato ShibataTetsunori IshikawaKatsumasa NomuraTatsuya NakamaDaigo MineYohei InoueKeiichi AshikagaNehiro KuriyamaAkihiko MatsuyamaTakuroh ImamuraYujiro AsadaKazuo Kitamura
Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent
John CosgraveGloria MelziSimon CorbettGiuseppe Biondi‐ZoccaiRade BabićFlavio AiroldiAlaide ChieffoGiuseppe SangiorgiMatteo MontorfanoIassen MichevMauro CarlinoAntonio Colombo
Drug-Eluting Stent Restenosis
John CosgraveGloria MelziGiuseppe Biondi‐ZoccaiFlavio AiroldiAlaide ChieffoGiuseppe SangiorgiMatteo MontorfanoIassen MichevMauro CarlinoErminio BonizzoniAntonio Colombo